MOLTENO bone graft research shares in $12 million grant - 29th Sep 2016

SilverBone research: antibacterial bone graft for dental surgery and implantology MOLTENO Ophthalmic's bone graft research and development project was boosted by a substantial grant from the New Zealand Government's Endeavour Fund. The project builds on MOLTENO Ophthalmic's established bone-derived products, the M-Sphere orbital implant and the MoaBone surgical implant and, working with the University of Otago's School of Dentisty and the Chemistry Department, aims to develop 'SilverBone', a bone graft material with antibacterial properties. The fund allocations were reported in the Otago Daily Times

Prof Warwick Duncan is leading the team of researchers. He has extensive experience with research into bone regeneration and is an expert on in-vivo testing of bone graft materials. The development and widespread use of dental implants has led to considerable interest in better bone grafting materials for use in the mouth, where there is a significant risk of bone resorbtion and graft infection. This exciting project aims to solve both the infection and resorbtion problems using the combined resources of MOLTENO Ophthalmic and the University of Otago.

« Back to News



Molteno® Ophthalmic Limited
PO Box 6322 Dunedin
New Zealand

Phone: +64 3 479 2744
Fax: +64 3 479 2444
Email: sales@molteno.com

site map | privacy statement | about | contact
 

Subscribe

RECEIVE UPDATES
FROM MOLTENO®

site powered by - Turboweb :: Simple Web Manager